« Back
Home /
Penpulimab

Penpulimab

Item no.	HY-P99108-5mg
Manufacturer	MedChem Express
CASRN	2350298-92-7
Amount	5 mg
Quantity options	100 mg 10 mg 1 ea 1 mg 5 mg
Category	Antibodies In Vivo Antibodies
Type	Biosimilars
Specific against	other
Purity	98.80
Citations	[1]Huang Z, et al. Penpulimab, an Fc-Engineered IgG1 Anti-PD-1 Antibody, With Improved Efficacy and Low Incidence of Immune-Related Adverse Events. Front Immunol. 2022 Jun 27;13:924542. [2]Yunlong Shan, et al. Anlotinib enhanced penpulimab efficacy through remodeling of tumor vascular architecture and immune microenvironment in hPD-L1/hPD-1 humanized mouse model. Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021) 2581-2581.
Smiles	[Penpulimab]
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Shipping condition	Cool pack
Available
Manufacturer - Type	Inhibitory Antibodies
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Targets	PD-1/PD-L1
Shipping Temperature	Blue Ice
Storage Conditions	Store at 4°C for 2 years, do not freeze
Product Description	Penpulimab is an IgG1 backbone anti-PD-1 monoclonal antibody with antitumor activities[1].
Manufacturer - Research Area	Cancer; Inflammation/Immunology
Solubility	H2O
Manufacturer - Pathway	Immunology/Inflammation
Clinical information	Phase 4

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-P99108-5mg-safety-datasheet.pdf